Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 932-938

  Gordien, Jean Baptiste ^a   Pigneux, Arnaud ^b   Vigouroux, Stephane ^b   Tabrizi, Reza ^b   Accoceberry, Isabelle ^c   Bernadou, Jean Marc ^a   Rouault, Audrey ^a   Saux, Marie Claude ^a   Breilh, Dominique ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

HPLC UV; Plasma; Solid phase extraction; Systemic azoles; Therapeutic drug monitoring

Indexed keywords

FLUCONAZOLE; HYDROXYITRACONAZOLE; ITRACONAZOLE; KETOCONAZOLE; LINEZOLID; POSACONAZOLE; RIFAMPICIN; VORICONAZOLE;

ACCURACY; ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG DETERMINATION; DRUG ELIMINATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; DRUG STABILITY; FLUCONAZOLE; HUMANS; ITRACONAZOLE; KETOCONAZOLE; PYRIMIDINES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS; TRIAZOLES; ULTRAVIOLET RAYS;

EID: 70349177213     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.06.030     Document Type: Article

References (11)

1. Boucher H.W., Groll A.H., Chiou C.C., and Walsh T.J. New systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 64 (2004) 1997-2020
2. Sanati H., Belanger P., Fratti R., and Ghannoum M. A new triazole: voriconazole (UK-109,496) blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob. Agents Chemother. 41 (1997) 2492-2496
3. Levêque D., Nivoix Y., Jehl F., and Herbrecht R. Clinical pharmacokinetics of voriconazole. Int. J. Antimicrob. Agents 27 (2006) 274-284
4. F.D.A Guidelines, Guidance for Industry, Bioanal. Method Validation, 2001.
5. Ullmann A.J., Cornely O.A., Burchardt A., Hachem R., Kontoyiannis D.P., Topelt K., Courtney R., Wexler D., Krishna G., Martinho M., Corcoran G., and Raad I. Pharmacokinetics, safety and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob. Agents Chemother. 50 (2006) 658-666
6. Geist M.J.P., Egerer G., Burhenne J., Riedel K.D., and Mikus G. Induction of voriconazole metabolism by rifampin in a patient with acute myeloic leukaemia. Antimicrob. Agents Chemother. 51 (2007) 3455-3456
7. Krieter P., Flannery B., Musick T., Gohdes M., Martinho M., and Courtney R. Disposition of posaconazole following single-dose oral administration in healthy subjects. Antimicrob. Agents Chemother. 48 (2004) 3543-3551
8. Ng T.K.C., Chan R.C.Y., Adeyemi-Doro F.A.B., Cheung S.W., and Cheng A.F.B. Rapid high-performance liquid chromatographic assay for antifungal agents in human sera. J. Antimicrob. Chemother. 37 (1996) 465-472
9. Krishna G., Sansone-Parsons A., Martinho M., Kantesaria B., and Pedicone L. Posaconazole plasma concentrations in juvenile patients with invasive fungal infections. Antimicrob. Agents Chemother. 51 (2007) 812-818
10. Khoschsorur G.A., Fruehwirth F., and Zelzer S. Isocratic HPLC method with UV detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxyl metabolite in human serum. Antimicrob. Agents Chemother. 49 (2005) 3569-3571
11. Chhun S., Rey E., Tran A., Lortholary O., Pons G., and Jullien V. Simultaneous quantification of voriconazole and posaconazole in human plasma by HPLC with UV detection. J. Chromatogr. B 852 (2007) 223-228